Heska Corp (HSKA) : Tfs Capital reduced its stake in Heska Corp by 27.24% during the most recent quarter end. The investment management company now holds a total of 84,385 shares of Heska Corp which is valued at $3,338,271 after selling 31,591 shares in Heska Corp , the firm said in a disclosure report filed with the SEC on May 10, 2016.Heska Corp makes up approximately 0.49% of Tfs Capital’s portfolio.
Other Hedge Funds, Including , Blackrock Institutional Trust Company N.a. reduced its stake in HSKA by selling 475 shares or 0.24% in the most recent quarter. The Hedge Fund company now holds 194,546 shares of HSKA which is valued at $7,696,240. Nine Chapters Capital Management sold out all of its stake in HSKA during the most recent quarter. The investment firm sold 13,400 shares of HSKA which is valued $530,104.Schwab Charles Investment Management Inc boosted its stake in HSKA in the latest quarter, The investment management firm added 8,326 additional shares and now holds a total of 16,417 shares of Heska Corp which is valued at $576,401.
Heska Corp closed down -0.94 points or -2.38% at $38.62 with 72,912 shares getting traded on Monday. Post opening the session at $39.91, the shares hit an intraday low of $38.06 and an intraday high of $39.91 and the price fluctuated in this range throughout the day.Shares ended Monday session in Red.
Many Wall Street Analysts have commented on Heska Corp. Heska Corp was Initiated by CL King to “Buy” on Apr 1, 2016.
Heska Corporation develops manufactures markets sells and supports veterinary products. The Company is focused on the canine and feline companion animal health markets. The Company operates in two segments: Core Companion Animal Health and Other Vaccines Pharmaceuticals and Products. The Core Companion Animal Health segment (CCA) includes primarily for canine and feline use blood testing instruments and supplies digital imaging products software and services and single use products and services such as heartworm diagnostic tests heartworm preventive products allergy immunotherapy products and allergy testing. The Other Vaccines Pharmaceuticals and Products segment (OVP) includes private label vaccine and pharmaceutical production primarily for cattle but also for other animals including small mammals.